2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Carcinoma, Hepatocellular
43
Liver Neoplasms
14
Colorectal Neoplasms
10
Recurrence
6
Cholangiocarcinoma
6
Neoplasm Metastasis
5
Pancreatic Neoplasms
3
Colonic Neoplasms
3
Rupture, Spontaneous
2
Postoperative Complications
2
Tissue Adhesions
1
Stomach Neoplasms
1
Secondary Malignant Neoplasm of Liver
1
Sarcopenia
1
Reperfusion Injury
1
Obesity, Morbid
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Metabolic Syndrome
1
Long-term Effects of Cancer Treatment
1
Liver Surgery
1
Liver Failure
1
Klatskin Tumor
1
Ischemia
1
Hypertension, Portal
1
Hemangioma
1
Focal Nodular Hyperplasia
1
Fibrosis
1
Disseminated Pancreatic Cancer
1
Disease Progression
1
Interventions
pembrolizumab
185
Gemcitabine
170
Paclitaxel
152
Carboplatin
137
Bevacizumab
128
Surveys and Questionnaires
118
Cisplatin
115
Docetaxel
114
Blood Specimen Collection
110
Cyclophosphamide
109
Exercise
108
Nivolumab
98
Fluorouracil
90
Capecitabine
86
Dexamethasone
81
Radiotherapy
80
Irinotecan
74
Standard of Care
69
Pemetrexed
68
Oxaliplatin
68
Leucovorin
64
Drug Therapy
64
Cetuximab
60
Erlotinib Hydrochloride
56
Sorafenib
53
atezolizumab
52
Ipilimumab
51
Doxorubicin
50
trametinib
47
Interviews as Topic
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Hepatectomy
×
Clear all
NCT01234701
2012-05-28
MRevaluation
University of Zurich
Completed
108 enrolled